Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoring.
Adult
Aged
Aged, 80 and over
Blood Pressure
/ drug effects
Blood Pressure Monitoring, Ambulatory
Creatinine
/ blood
Diabetes Mellitus, Type 2
/ blood
Female
Glycated Hemoglobin
/ metabolism
Humans
Hypertension
/ complications
Hypertension, Renal
/ etiology
Hypoglycemic Agents
/ pharmacology
Japan
Kidney
/ physiopathology
Male
Masked Hypertension
/ complications
Middle Aged
Renal Insufficiency, Chronic
/ complications
Retrospective Studies
Serum Albumin
/ metabolism
Sodium-Glucose Transporter 2 Inhibitors
/ pharmacology
White Coat Hypertension
/ complications
Sodium glucose co-transporter 2 inhibitors
albumin-creatinine ratio
chronic kidney disease
home blood pressure monitoring
masked hypertension
Journal
Clinical and experimental hypertension (New York, N.Y. : 1993)
ISSN: 1525-6006
Titre abrégé: Clin Exp Hypertens
Pays: England
ID NLM: 9305929
Informations de publication
Date de publication:
2019
2019
Historique:
pubmed:
31
10
2018
medline:
27
11
2019
entrez:
31
10
2018
Statut:
ppublish
Résumé
Decrease in blood pressure contributes to the reno-protective effects of sodium-glucose cotransporter 2 inhibitors; however, its relationship with home monitoring of blood pressure is unclear. We retrospectively analyzed 101 visiting members of the Kanagawa Physicians Association with type 2 diabetes mellitus and chronic kidney disease who were taking sodium-glucose cotransporter 2 inhibitors and who monitored blood pressure at home for a median treatment period of
Identifiants
pubmed: 30373408
doi: 10.1080/10641963.2018.1529778
doi:
Substances chimiques
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Serum Albumin
0
Sodium-Glucose Transporter 2 Inhibitors
0
hemoglobin A1c protein, human
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM